Sources of information and trends
Under the radar.July-September | 2017
Cost to become public represents 4.8% of the initial offer's value
Conclusion from Deloitte's study, in partnership with B3, which covered IPOs carried out over 12 years
The IPO cost in Brazil stood at 4.8% of the distributed value of initial offerings released by companies that held IPOs (Initial Public Offerings) in the last 12 years, according to the median ascertained by a study performed by Deloitte, in partnership with B3 – Brasil, Bolsa, Balcão. The investment required is precisely one of the main concerns of private companies that want to enter the stock market.
With the purpose of bringing useful information to the Brazilian capital market participants, and also to potential interested in joining it, the survey “IPO Costs in Brazil – An analysis of the offerings between 2005 and 2017” was conducted with 198 companies that became public or carried out subsequent stock offerings (the so-called follow-ons) between January 2005 and April 2017.
The commissions, represented by the expenses on coordinators, were identified as the largest cost for a company that wants to go public. In the list of expenses, there are also those related to lawyers, consultants and auditors.
The report shows that, while commissions present variable costs, other expenses present fixed cost characteristics, being consistently reduced by the increase in the volume of distributions.
In 2017, the offers presented a bias to increase when compared with the previous years. Until April 2017, three offerings were recorded, the highest number since 2014.
Access the study “IPO Costs in Brazil” in its entirety (in Portuguese).
Luxury goods retail is still growing, mainly in emerging markets
China, Russia and the United Arab Emirates lead the sector's consumption increase
The luxury goods market is still a good deal. The conclusion is from the 4th edition of the “Global Powers of Luxury Goods” survey developed by Deloitte. The study indicates that the world’s 100 largest luxury goods companies generated sales of US$ 212 billion, according to data for the last fiscal year with comparable information among participating organizations.
The study points out that consumers in emerging economies continue to boost the worldwide growth of the luxury goods segment. In China, Russia and the United Arab Emirates, the percentage of consumers claiming to have increased their spending on luxury goods in the last five years was 70%, compared to 53% in more mature markets such as the European Union, United States and Japan.
Restoque – retailer owner of brands such as Le Lis Blanc and Dudalina – is the only Brazilian company listed in the ranking, in 74th place, being the second consecutive time that it appears in the survey. In 2016, the Brazilian company was on 79th place.
The report points out that, in this market, there is a great appreciation for the unique purchase experience and differentiated service – factors that are considered major assets among luxury brands.
Access the 2017 edition of study “Global Powers of Luxury Goods” in its entirety.
HR increases investment in technology
Number of companies that have invested in the computerization of the career management area doubled compared to 2016
How the digital age challenges affect business and the Human Resources area of companies – this is the central theme of the “26th edition of the National Survey on Compensation and Trends” conducted by Deloitte with 140 companies from various segments in the Southeast, Midwest, South, North and Northeast of the country.
Although the level of investment in career management technology is still low (24% of participant companies made investments in the area), its growth was exponential, since, in 2016, this percentage was only 12%. Amounts intended for the areas of equipment, facilities and processes are also expected to grow 20% in 2017 compared to the percentage recorded in the previous year.
The report indicates that, in 2017, 62% of the positions were reduced or maintained a salary level similar to 2016 and 38% had an increase in the real salary level – in 2016, this number was 24%. Moreover, most companies (54%) indicated they foresee the maintenance of the number of employees and about 24% estimate a growth in its workforce. In 2016, only 8% of surveyed organizations indicated an increase in the number of employees.
Another relevant indicator of the study points the companies’ concern with employee training, these investments jumped from 27% in 2016 to 42% in 2017.
Access the “2017 National Survey on Compensation and Trends” in its entirety (in Portuguese).
Innovation and resource management remain crucial in the health care industry
Collaborative development of products and operational restructuring are paths for the greater efficiency in the sector
In the search for the perfect triad – improve health, improve service and reduce expenses – the health care industry needs to reinvent itself. The 2017 editions of the studies “Global Health Care Outlook” (aimed at the health care industry) and “Global Life Sciences Outlook” (aimed at the pharmaceutical and laboratory industry), conducted by Deloitte, address how innovation and resource management contribute for the health care industry to obtain the “more for less” effect.
Increasingly, health and quality of life themes will have financial impact for companies, institutions and governments. To deal with the constant changes, it will be necessary to incorporate innovations in business models. The study of trends for the health care industry indicates that there is need for transformation in the way health care companies deal with prevention, diagnosis, monitoring and treatment of diseases.
The trend analysis for the health care industry indicates that the sector’s institutions are innovating through multiple paths to achieve their goals of quality, cost and efficiency. Among them, we highlight the collaborative development of products, portfolio management, operational restructuring, growth through mergers and acquisitions and the human capital transformation.
The trends study for the pharmaceutical and laboratory industry, in turn, identifies a chain fragmentation, in which each link operates differently, with different tools, technologies and processes. Implementing elements that integrate this chain can be of great relevance to the segment. Another conclusion points out that the use of management platforms, including analytics and big data, can be a solution to integrate relevant points to cost control.
Deseja receber conteúdos da Mundo Corporativo e da Deloitte em primeira mão?Cadastre-se